Mazdutide
Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
Innovent · Phase 1/2 · Completed · Enrollment 60
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.